David Gao

Biography

China’s plasma-based biopharmaceutical industry is in its infancy stage, and the plasma products market is still under-penetrated. Our expertise in the development and commercialization of plasma products has been the key driver for our success. We will continue to leverage our expertise to further solidify our market leadership. Building on our strong research and development position, we are committed to expanding our product portfolio and pipeline to include more technologically advanced, higher-margin products, many of which are used in the United States and other developed markets, but are not currently manufactured in China.

Research Interest

Pharmaceutical